PUT - SPRINTER OPEN END - EDWARDS LIFESCIENCES | Market Closed - Deutsche Boerse AG 11:15:12 20/05/2024 pm IST | ||
| 1.72 EUR | -2.27% |
|
| Current month | -20.37% | ||
| 1 month | -16.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 20/24/20 | 1.72 | -2.27% |
| 17/24/17 | 1.76 | +7.98% |
| 16/24/16 | 1.63 | -4.12% |
| 15/24/15 | 1.7 | -17.87% |
| 14/24/14 | 2.07 | -2.82% |
Delayed Quote Deutsche Boerse AG
Last update May 20, 2024 at 11:15 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM9RLD |
| ISIN | DE000VM9RLD4 |
| Date issued | 05/02/2024 |
| Strike | 107.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.09 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.18 € |
|---|---|
| Lowest since issue | 1.14 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.78
USD
Average target price
95.9
USD
Spread / Average Target
+6.82%
- Stock Market
- Certificates
- Certificat
